Life Sciences Group Of The Year: Gibson Dunn
Gibson Dunn's life sciences practice scored a last-minute injunction for Sanofi-Aventis in a complex battle over an insulin injection device and protected the company from allegations it overcharged the U.S. hundreds...To view the full article, register now.
Already a subscriber? Click here to view full article